General cellular proteins and enzymes

The entry "General cellular proteins and enzymes" is not a specific, canonical molecule or receptor. Instead, it is a broad, non-specific category encompassing thousands of distinct biomolecules. This makes it not suitable as a structured drug discovery target without further specification. The term "General cellular proteins and enzymes" refers collectively to the vast array of proteins found in cells, including structural proteins, receptors, enzymes, and regulatory proteins. Enzymes represent a major subclass and are defined as proteins (with some exceptions, like ribozymes) that accelerate biochemical reactions essential for life without being consumed in the process. Enzymes are classified into families such as oxidoreductases, transferases, hydrolases, lyases, isomerases, ligases, and translocases, each responsible for catalyzing a general type of biochemical reaction[1][2][3][4][5][6]. However, due to its inclusivity and lack of specificity, "General cellular proteins and enzymes" is not recognized as a single molecular target in therapeutic development, and should not be used as a drug target entry. Justification: The term is too broad and lacks specificity, covering many unrelated proteins and enzymatic targets. It does not correspond to a unique molecular entity or family suitable for structured annotation or drug development. Such entries should be replaced by precise targets (such as "Epidermal growth factor receptor" or "Tyrosine-protein kinase ABL1" or "DNA polymerase delta") with clear molecular and pharmacological context. No canonical abbreviation or unambiguous aliases exist. No structured list of interacting drugs or mechanisms of action is valid for such a heterogeneous group. If your aim is to structure a drug target database, individual proteins or enzymes must be listed separately by their specific canonical names.